JPY 2137.0
(1.71%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Operating Cash Flow | 2.65 Billion | 1.76 Billion | 1.58 Billion | 1.26 Billion |
Net Income | 1.66 Billion | 663 Million | 463 Million | 69 Million |
Depreciation & Amortization | 1.02 Billion | 1 Billion | 975 Million | 955 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | 732 Million | 295 Million | 77 Million | 75 Million |
Other non-cash items | -1.04 Billion | -217 Million | 168 Million | -8 Million |
Investing Cash Flow | -1.94 Billion | -371 Million | -614 Million | -1.8 Billion |
Investments in PPE | -2.08 Billion | -1.63 Billion | -1.2 Billion | -1.58 Billion |
Acquisitions | - | -60 Million | -117 Million | -30 Million |
Investment purchases | - | - | -117 Million | -39 Million |
Sales/Maturities of investments | 102 Million | - | - | 9 Million |
Other Investing Activities | 1 Million | -1 Million | -200 Million | -6 Million |
Financing Cash Flow | -327 Million | -1.4 Billion | -858 Million | 893 Million |
Debt repayment | -1.32 Billion | -1.35 Billion | -828 Million | -255 Million |
Dividends payments | -48 Million | -19 Million | -19 Million | -15 Million |
Common Stock Repurchased | -809 Million | - | - | - |
Common Stock Issuance | 1.95 Billion | - | - | 675 Million |
Other Financing Activities | -1 Million | -23 Million | -3 Million | -13 Million |
Accounts receivables | 190 Million | 953 Million | -147 Million | 69 Million |
Accounts payables | 573 Million | 60 Million | 203 Million | -112 Million |
Inventory | -230 Million | -650 Million | -47 Million | 97 Million |
Other working capital | -868 Million | -312 Million | -25 Million | -479 Million |
Cash at beginning of period | 1.3 Billion | 1.28 Billion | 1.1 Billion | 760 Million |
Cash at end of period | 1.71 Billion | 1.3 Billion | 1.28 Billion | 1.1 Billion |
Capital Expenditure | -2.08 Billion | -1.63 Billion | -1.2 Billion | -1.58 Billion |
Effect of forex changes on cash | 26 Million | 26 Million | 58 Million | - |
Net cash flow / Change in cash | 409 Million | 20 Million | 174 Million | 347 Million |
Free Cash Flow | 570 Million | 131 Million | 383 Million | -321 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 335 Million | 147 Million | 1.66 Billion | 369 Million | 245 Million | 397 Million |
Depreciation & Amortization | - | - | 1.02 Billion | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 732 Million | - | - | - |
Other non-cash items | -335 Million | -147 Million | -1.04 Billion | -369 Million | -245 Million | -397 Million |
Investing Cash Flow | - | - | -1.94 Billion | - | - | - |
Investments in PPE | - | - | -2.08 Billion | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | 102 Million | - | - | - |
Other Investing Activities | - | - | 1 Million | - | - | - |
Financing Cash Flow | - | - | -327 Million | - | - | - |
Debt repayment | - | - | -1.32 Billion | - | - | - |
Dividends payments | - | - | -48 Million | - | - | - |
Common Stock Repurchased | - | - | -809 Million | - | - | - |
Common Stock Issuance | - | - | 1.95 Billion | - | - | - |
Other Financing Activities | - | - | -1 Million | - | - | - |
Accounts receivables | - | - | 190 Million | - | - | - |
Accounts payables | - | - | 573 Million | - | - | - |
Inventory | - | - | -230 Million | - | - | - |
Other working capital | - | - | -868 Million | - | - | - |
Cash at beginning of period | - | - | 1.3 Billion | - | - | - |
Cash at end of period | - | - | 1.71 Billion | - | - | - |
Capital Expenditure | - | - | -2.08 Billion | - | - | - |
Effect of forex changes on cash | - | - | 26 Million | - | - | - |
Net cash flow / Change in cash | - | - | 409 Million | - | - | - |
Free Cash Flow | - | - | 570 Million | - | - | - |
GTK
9680
HLBBF
OCLN
BKRIY
DEXSF